Patents by Inventor Stephen Pak

Stephen Pak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS OF AUTOPHAGY MODULATING AGENTS AND USES THEREOF
    Publication number: 20250144110
    Abstract: Among the various aspects of the present disclosure is the provision of compositions and methods for modulating autophagy for treatment and prevention of autophagy-associated diseases, disorders, or conditions and compositions of photoreactive compounds. An aspect of the present disclosure provides for autophagy enhancing agents capable of treating or preventing diseases, disorders, or conditions in which autophagy is implicated.
    Type: Application
    Filed: January 27, 2023
    Publication date: May 8, 2025
    Applicant: Washington University
    Inventors: David Perlmutter, Roland Dolle, Stephen Pak, Gary Silverman
  • Compositions and methods of use thereof for treatment of proteinopathies
    Patent number: 11931366
    Abstract: The present disclosure relates generally compositions and methods of using the same for the treatment of proteinopathies (e.g. Alpha-1-antitrypsin deficiency, Non-alcoholic fatty liver disease, Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis, and Huntington's disease) with one or more proteotoxicity reducing agents.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: March 19, 2024
    Assignee: Washington University
    Inventors: Stephen Pak, David Perlmutter, Gary Silverman
  • COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF PROTEINOPATHIES
    Publication number: 20210228591
    Abstract: The present disclosure relates generally compositions and methods of using the same for the treatment of proteinopathies (e.g. Alpha-1-antitrypsin deficiency, Non-alcoholic fatty liver disease, Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis, and Huntington's disease) with one or more proteotoxicity reducing agents.
    Type: Application
    Filed: April 19, 2019
    Publication date: July 29, 2021
    Inventors: Stephen Pak, David Perlmutter, Gary Silverman